Buffalo-Niagara to be hub for medical marijuana research and growth

AMHERST, N.Y. (WKBW) - Dent Neurologic Institute (DNI) in Amherst is partnering with a Lewiston business to become a clinical research center for the use of medical marijuana.

Dent and Herbal Agriculture (HA) will be working together to develop treatment and protocol for treating neurological disorders with marijuana.

DNI's Chief Medical Officer, Laszlo Mechtler stated, "We are pleased to have partnered with HA to develop protocols for the treatment of NYS approved neurological disorders, which includes, ALS (Lou Gehrig's disease), Parkinson's disease, Multiple Sclerosis (MS), spinal cord injury, epilepsy, neuropathies and Huntington's disease. Additionally, the DNI will focus on clinical protocols involving patients with chronic migraine and Post Traumatic Stress Disorder. We fully anticipate advancing the science, treatment and research on behalf the individual patients and their families whom could benefit greatly from medical marijuana's therapeutic benefits."

Gary Smith, Chief Operating Officer of Herbal Agriculture commented, "We are extremely excited...

Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.


URL: 
http://www.wkbw.com/news/dent-neurologic-turns-to-medical-marijuana